vimarsana.com

Latest Breaking News On - Rxsight inc - Page 1 : vimarsana.com

Oculis Publishes Results of 2024 Annual General Meeting and Announces Appointments to its Board of Directors and Scientific Advisory Board

ZUG, Switzerland, May 30, 2024 Shareholders approved all agenda items and proposals of the Board of DirectorsRobert K. Warner, M.B.A. and Arshad M. Khanani, M.D., M.A., FASRS elected as members.

Aigen Investment Management LP Has $373,000 Stock Holdings in RxSight, Inc (NASDAQ:RXST)

Aigen Investment Management LP Has $373,000 Stock Holdings in RxSight, Inc (NASDAQ:RXST)
wkrb13.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wkrb13.com Daily Mail and Mail on Sunday newspapers.

Buy 5 Medical Instruments Stocks to Enhance Your Portfolio - Hologic (NASDAQ:HOLX), Alcon (NYSE:ALC)

The Medical Instruments industry has been witnessing a gradual transition from remote healthcare and contactless services during the pandemic to its original space of point-of-care testing, heavy as well as minimally invasive implants, elective procedures, and so on. This industry is highly fragmented, with participants engaged in research and development (R&D) in therapeutic areas.

RxSight Boost From Eye Lens Replacement - Orange County Business Journal

RxSight Boost From Eye Lens Replacement - Orange County Business Journal
ocbj.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from ocbj.com Daily Mail and Mail on Sunday newspapers.

RxSight, Inc (NASDAQ:RXST) Given Consensus Recommendation of Buy by Brokerages

RxSight, Inc. (NASDAQ:RXST – Get Free Report) has earned a consensus rating of “Buy” from the seven brokerages that are currently covering the firm, MarketBeat.com reports. Seven research analysts have rated the stock with a buy rating. The average twelve-month price target among analysts that have updated their coverage on the stock in the last […]

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.